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Dust mite allergens are important triggers of atopic asthma. Differential allergenic 
properties can however be observed in different groups of antigens. Existing lab 
research on recombinant allergens and available information on the IgE-binding 
capacity and distribution of dust samples in the environment of various dust mite 
allergen groups enabled us to postulate that these differences may be related to 
multiple factors including (exposure) level in the environment and inherent host-
allergen interactions such as host airway and antibody responses to the allergens. 
In our assays, we used native Der p 1 and recombinant Der p 2, Blo t 3, Blo t 5, 
Der p 7, Blo t 12, and Der f 13 to represent each of the allergen group selected for 
the panel of study: Groups 1, 2, 3, 5, 7, 12, and 13.  
Atopic sera reactivity and house dust sample screens were carried out to 
profile the allergens in the local context.  We then investigated the intrinsic nature 
of the dust mite proteins and the allergen-host interaction response by designing a 
murine model of atopic asthma. Host immune responses to each allergen were 
measured by airway hyperresponsiveness (AHR), sera allergen-specific antibody 
profile, and lung histology.  
 For the IgE-binding capacity profiles, we conclude that allergens with both 
high capacity of IgE-binding were Der p 2, Der p 1 and Blo t 5 whereas allergens 
with low IgE-binding capacity are Der f 13 > Blo t 3 > Der p7 > Blo t 12 
(magnitude) and Blo t 12 > Der p 7 > Blo t 3 > Der f 13 (frequency). From the 
environmental dust screens, Der p 1 and Der p 2 were categorized as having high 
environmental distribution levels, Blo t 5 and Der f 13 as moderate and Der p 7, 
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Blo t 3 and Blo t 12 as poorly distributed. Groups 1 and 2 exhibited expected IgE 
and IgG1 production. However, Der p 1 did not induce any significant AHR 
trending compared to Der p 2. Comparisons between groups 2 and 13 can be 
drawn by their similarity in size and function. Interestingly, both groups 
demonstrated opposite effects on host AHR and antibody production. Blo t 12 also 
induced AHR suppression at high immunization doses, similar to Der f 13. Blo t 5 
was able to induce increased AHR but only with immunization doses 5-fold 
higher. Der p 7 was able to induce increased AHR with elevated production of 
IgG1 at low immunization doses suggesting IgE tolerance. Groups 3 and 12 data 
corroborate them as minor allergens in comparison with major allergens such as 
groups 1 and 2. 
From the atopic population sera reactivity screens, the house dust 
distribution levels and the AHR responses were then analyzed to form a better 
profile of each allergen group. This study has demonstrated that each allergen 
group can exhibit differential host immunological responses and this may be 
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Chapter 1: Introduction 
 
1.1 Allergy and asthma 
 
An antigen is any ubiquitous molecule that can be specifically recognized by the 
adaptive immune system and the specific recognition of it is the driving force of 
all adaptive immune responses. Often used interchangeably with the term antigen 
is the term allergen, which is defined as an antigenic substance capable of 
inducing an immediate type hypersensitivity reaction (i.e. allergy). Most people 
will have an immunological response to every antigen encountered in the 
environment but with varying degrees of response depending on his or her genetic 
predisposition that underlies the nature of response. Most responses are not 
harmful as the antigens are naturally cleared by the immune system but an atopic 
response may lead to clinical phenotypes such as allergic sensitization, clinical 
disease such as dermatitis, allergic rhinitis and chronic inflammatory responses 
such as asthma.  
There is currently no precise definition for atopy yet but a definition 
proposed by EAACI, (Johansson et al., 2001), stated that atopy is `a familial 
tendency to produce IgE antibodies to low doses of allergens, and to develop 
typical symptoms such as asthma, rhinoconjuctivitis, or eczema/dermatitis’. This 
atopic response or state of hypersensitivity induced by contact with a particular 
antigen (allergen) is commonly known as allergy and classified by Coombs and 
Gell (Coombs, 1975) as a type I hypersensitivity reaction. 
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 Environmental allergens come from a variety of sources such as trees, 
grasses, fungi, food, mites, cats, dogs and bees. They are commonly found and 
widely distributed but a subset of only less than 1% to almost 10% of the 
population actually develops IgE responses to these allergens and go on to have a 
clinically significant allergic disease (Hayglass, 2003). However, this subset 
accounts for a pronounced cost on global health and quality of life. For example, 
an estimated 100–150 million people suffer from atopic asthma worldwide, and 
the disease claims 180,000 lives annually (Sly, 1999). The global expenditure for 
medical treatment of asthma is about USD12.7 billion per annum (Weiss and 
Sullivan, 2001).  In Singapore, 1 in 5 school children (Goh et al., 1996) and 4% of 
the adult population (Ng et al., 1994) were reported to have asthma. More than 
90% of patients with asthma and/or allergic rhinitis to dust mites and other 
inhalant allergens are found to be sensitized to Blomia tropicalis, 
Dermatophagoides pteronyssinus and Dermatophagoides farinae (Chew et al., 
1999). Although asthma is a complex multifactorial disease, atopy presents a vital 
risk factor for asthma, especially with the most significant period of allergy 
sensitization development to allergens being in early childhood (Peden, 2002). A 
summary of the mechanism of allergy in the pathogenesis of atopic asthma is 
shown in Figure 1.  
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 Figure 1: Atopic asthma (adapted from the HOPGENE Program for Genomic 
Applications; John Hopkins University USA, 2003 web resource) 
 
 
In order to induce allergy, sensitization must first take place. Atopic 
individuals usually already have existing specific antibodies circulating in their 
bloodstream, due to exposure to soluble allergens at mucosal surfaces from as 
young as early post-natal years (Niederberger et al., 2002; Kulig et al., 1999; 
Wahn et al., 1997). Upon uptake of allergen by antigen-presenting cells (APC),  
T cell–B cell interactions occur to induce specific B cells to switch 
immunoglobulin classes into IgE. IgE+ memory B cells and allergen-specific 
memory T cells are then established and boosted each time the allergen is 
repeatedly encountered. In an immediate phase reaction, cross-linking of effector 
cell-bound IgE by allergens releases biologically active mediators such as 
leukotrienes and histamines (e.g. mast cell degranulation), which causes 
symptoms of allergy. The late phase reaction occurs 2–24 hours after contact with 
allergen and involves proliferation of activated Th2 cells in response to the 
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allergens. Proinflammatory cytokines such as IL-4, IL-5 and IL-13 are released 
that promotes recruitment of eosinophils (Valenta, 2002). This early and late 
phase responses corresponds to what occurs in atopic asthma. 
 
1.2 Dust mite allergens 
 
There are over 30 different proteins in a house dust mite extract that are 
able to induce IgE in dust mite-sensitive individuals (Thomas, 2002). To date, 
these proteins ranging from 7.2–114.0 kDa in molecular weight size have been 
classified into 21 groups (Table 1) based on their size, similarities in biochemical 
properties and sequence homology. The allergens are named according to the 
systematic nomenclature for disease-causing allergens that is formulated by a 
subcommittee of the World Health Organization (WHO) and the International 
Union of Immunological Societies (IUIS) and satisfy criteria of biological purity 
and allergenic importance (WHO/IUIS, 1994). Table 1 shows that among the 
described allergen groups of dust mites, group 1 and group 2 allergens which are 
known to be present in high concentrations in house dust (Custovic et al., 1996; 
Platts-Mills & Chapman, 1994), have the strongest IgE-binding capacity. Most of 
the dust mite allergen groups were identified in Dermatophagoides spp. followed 


























70–90 Der f 1 (Dilworth et al., 1991), 
Der p 1 (Chua et al., 1988), 
Der m 1 (Lind et al., 1988), 
Eur m 1 (Kent et al., 1992), 
Blo t 1 (Mora et al., 2003). 
 
2 Unknown 14 60–90 
 
Der f 2 (Trudinger et al., 1991), 
Der p 2 (Chua et a.,l 1990), 
Tyr p 2 (Eriksson et al., 1998), 
Eur m 2 (Smith et al., 1999), 
Gly d 2 (Gafvelin et al., 2001), 
Lep d 2 (Varela et al., 1994). 
 
3 Trypsin 28,30 51–90 Der f 3 (Nishiyama et al., 1995), 
Der p 3 (Smith et al., 1994), 
Eur m 3 (Smith et al., 1999b)b, 
Blo t 3 (Cheong et al., 2003). 
 
5 Unknown 15 9–70 Der p 5 (Tovey et al., 1989), 
Blo t 5 (Arruda et al., 1995), 




25 30–40 Der f 6 (Kawamoto et al.,1999), 
Der p 6 (Yasueda et al., 1993). 
 




Der p 7 (Shen et al., 1993), 
Der f 7 (Shen et al., 1995), 









30 >90 Der p 9 (King et al.,1996). 
 
10 Tropomyosin 33–37 5-80 Der p 10 (Asturias et al., 1998), 
Der f 10 (Aki et al., 1995), 
Blo t 10 (Yi et al., 2002), 






80 Der f 11 (Tsai et al., 1999), 
Der p11 (Tategaki et al., 2000), 
Blo t 11 (Ramos et al., 2001). 
 










Blo t 13 (Caraballo et al., 1997), 
Lep d 13 (Eriksson et al., 2001), 
Aca s 13 (Eriksson et al., 1999). 









Der f 14 (Fujikawa et al., 1996), 
Eur m 14 (Epton et al., 1999), 
Der p 14 (Epton et al., 2001). 
 































40 ? Der p 20b 





protein 70 kDa 
70 10 Der f (Aki et al., 1994) 
 
Table 1: Dust mite allergens.  
Species name of dust mites: Der f (D. farinae), Der p (D. pteronyssinus), Der m 
(D. microceras), Eur m (Euroglyphus maynei), Tyr p (Tyrophagus putrescentiae), 
Lep d (Lepidoglyphus destructor), Gly d (Glycyphagus domesticus), Blo t (Blomia 
tropicalis), and Aca s (Acarus siro). 
aListed in the WHO/IUIS list of allergens as of June 2006 
(http://www.allergen.org/List.htm) 
bUnpublished but sequence data available in WHO/IUIS list of allergens or 
GenBank. 
cData for Mag allergen 
dData for recombinant Mag 3 allergen 
eData for natural Mag 3 allergen 
fNot listed in WHO/IUIS list of allergens but published and sequence data 
available in GenBank. 
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More than 95 % of the allergen accumulated in mite cultures is found in 
fecal particles (Tovey et al., 1981), which makes mite feces a major source of 
house dust allergen. Dust mite allergens have already been detected in household 
niches worldwide. For an atopic individual, it takes lesser amounts of allergens to 
invoke an immune response compared to a non-atopic individual. Studies have 
previously been conducted and are also ongoing to correlate the amount of 
allergen found in environmental dust with the risk of allergen sensitization. Many 
functions of the dust mite allergen groups have been elucidated except for groups 
2, 5, 7, 12 and 21. Their diverse biological functions include enzymes, enzyme 
inhibitors, ligand binding proteins and structural proteins. 
Dust mite allergens are one of the most important aeroallergens inducing 
asthma and are much more relevant than ovalbumin which is the standard antigen 
used in murine models of atopic asthma. There is also a lack of animal models 
using dust mite allergens as the allergen source (Sharma et al., 2003). The 
available studies of atopic asthma using dust mite allergens have mostly been 
limited to house dust mite extracts (Tategaki et al., 2002; Tumas et al., 2001) 
rather than the use of recombinant proteins. The content of extracts includes a 
variety of allergenic and non-allergenic components which are often difficult to 
standardize or ensured free of contamination from other non-dust mite proteins. 
Positive reactions to a given allergen extract will indicate that an allergic subject 
is sensitized against extract components without identifying the specific 
components. Hence, the use of recombinant allergens allows for specific 
quantification of host response to allergen groups investigated. 
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1.3 Murine models of atopic asthma 
 
The Mouse Genome Project has revealed that mice and humans both have 
about 30,000 genes and share 99% of those genes alike. About 1,200 new genes 
were discovered in the human genome because of mouse-human comparisons  
(90 % of genes associated with diseases are identical in human and mouse). The 
availability of well-characterized mutants and inbred strains provide a wealth of 
information and opportunities (Renz et al., 2002). Different strains vary in 
phenotypes and susceptibility to disease induction, echoing the heterogeneity in 
humans (Gosselin et al., 2002). There are also many available antibodies and 
reagents that are specific to the mouse. These collectively make the mouse a very 
useful model to study the pathogenesis of human diseases. In the last decade itself, 
many advances in understanding the mechanism of asthma and allergy have been 
made with the use of murine models. These studies have also proven useful in 
characterizing specific allergen-induced immunological responses and 
immunological properties of allergens. 
BALB/c and C57BL/6j are two of the commonest strains of mice used in 
studies of allergies and atopic asthma. One of the main factors to consider when 
choosing a strain is its airway responsiveness to allergen-induced challenges. The 
rank of order for airway responsiveness among inbred murine strains is already 
well studied: A/J > BALB/c > C3H/HeJ > C57BL/6j (Duguet et al., 2002). 
Sensitized BALB/c mice have greater AHR compared to C57BL/6j mice (Brewer 
et al., 1999; Zhang et al., 1999). BALB/c mice develop allergen-induced  
Th2-cytokines gene expression, airway inflammation and hyperresponsiveness 
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whereas C57BL/6j mice are less reactive (Gosselin et al., 2002; Yip et al., 1999) 
making them suitable for comparison work between a responder and  
non-responder strain.  
Different laboratories perform murine experiments differently in studying 
atopic asthma as there is no standard experimental protocol which is also not 
feasible considering the vast kinds of studies that are performed with different 
variables. Each experimental protocol is usually designed to exhibit the hallmark 
features of a murine model of atopic asthma which are bronchial eosinophilic 
inflammation and airway hyperresponsiveness (AHR) (Leong & Hudson., 2001). 
To produce a murine model, mice are usually injected with an antigen to induce 
systemic sensitization before the same antigen is then administered through the 
airways to focus the inflammatory process in the bronchi and lungs. Mice exposed 
to an antigen only through the respiratory route develop AHR without histologic 
airway inflammation (Hessel et al., 1995 & Renz H, et al. 1992). Systemic antigen 
sensitization with the use of an adjuvant or intratracheal challenge is the most 
common antigen administration route used (Tumas et al., 2001). Allergen-specific 
IgE is measured as risk factor for asthma as well as the allergenicity of the 
allergen whereas IgG1 is measured because it is also able to bind mast cells and 
basophils to cause degranulation (Tumas et al., 1991).  
Experimental protocols mostly differ in the age of animals used, dose and 
type of allergen, route of allergen administration, length of allergen exposure and 
method of measuring AHR. These differences tend to make comparison of 
published results difficult. For example, the dose of ovalbumin (a commonly 
investigated allergen) for systemic sensitization varies from 1 μg (Nakajima et al., 
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1994)   to 8,000 μg (Wilder et al., 1999). Furthermore, in a dose-comparison study, 
10 μg of ovalbumin established a working asthma model, but 1,000 μg failed to do 
so (Sakai et al., 1999). Commonly measured parameters include sera allergen-
specific immunoglobulin levels, AHR, lung histology, cell infiltration counts, and 
bronchoalveolar lavage fluid (BALF) cytokine levels. 
 
1.4 Aims of this study 
 
This thesis focuses on characterizing the immunological properties of 7 
selected dust mite allergen groups in the context of elucidating the pathogenesis of 
atopic asthma. The dust mite allergen groups 1, 2, 3, 5, 7, 12 and 13 were selected 
based on published IgE-binding profiles for each allergen and house dust 
distribution data as well as their biological functions (known or putative). Some 
groups are similar and yet most are different. Together they represent the dust 
mite allergens across a broad spectrum of immunogenicity. In our assays, the 
allergen groups mentioned were represented by native Der p 1 and recombinant 
Der p 2, Blo t 3, Blo t 5, Der p 7, Blo t 12 and Der f 13.  
We were interested to find out if the specific immunogenicity of each 
allergen group depended on its IgE-binding capacity, its concentrations in the 
environment and/or its intrinsic biochemical properties. Therefore, we 
investigated the sera reactivity of a selected Singaporean atopic population to 
these allergens and the respective allergen distribution and concentrations in local 
Singaporean households. We were also intrigued by how each of the selected 
allergen groups would interact with the immune system of an atopic host. What 
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are the differences or similarities between the groups in the context of inducing an 
immunological response? Therefore, we have chosen a murine model of atopic 
asthma to characterize host immunological responses to the allergen groups such 
as serum antibody and airway responses. A primary motivation for this study is 
that dust mite allergens present the highest sensitization risk for atopic and 
childhood asthma in our local population of Singapore.  
Through this study, we aim to better understand the mechanisms of allergy 
sensitization and the role of dust mite allergens in the pathogenesis of atopic 
asthma. This study also provided materials (lungs, sera and BAL fluid from mice 
immunized with and exposed to dust mite allergens) for future functional genomic 
and proteomic characterization of dust mite allergen-induced responses in a host 
immune system. Such future characterization will yield possible clues into 
putative molecular markers or pathways of target in the pathogenesis of atopic 
asthma.  
The main deliverables of this study were local population sera IgE-binding 
reactivity profiles of the allergens, the concentrations of the allergen groups in the 
local environment and the specific immunological responses elicited by these 
allergen groups as measured by airway hyperresponsiveness (AHR), serum 











Chapter 2: Material and Methods 
 
2.1 Production of recombinant allergens and allergen-specific antibodies 
 
2.1.1 Expression and purification of recombinant allergens 
 
Protein expression of soluble recombinant allergens was carried out by 
transforming plasmids containing DNA inserts of wild type allergens into E. coli 
strain BL21 (DE3) cells. 1.0 mM IPTG was used to induce the cultures at 37 ˚C 
for 4 hrs with constant shaking at 200 rpm. The induced cultures were centrifuged 
to collect the bacterial cells (5000 rpm, 20 mins, 4 ˚C), then resuspended in 
binding buffer (5mM imidazole, 0.5M NaCl, & 20mM Tris-HCl pH 7.9). Cells 
were then lysed by sonication to obtain the recombinant proteins. The supernatant 
from the pelleted lysate was purified using Ni-NTA resin (Novagen; USA) under 
denaturing conditions and eluted from the Ni-NTA resin using elution buffer (1M 
imidazole, 0.5M NaCl, & 20mM Tris HCl pH 7.9). Bacterial cells containing 
insoluble recombinant allergens were resuspended in binding buffer (5mM 
imidazole, 0.5M NaCl, & 20mM Tris-HCl pH 7.9) added with 6 M guanidine 
hydrochloride. The proteins were then refolded by rapid dilution into their 
respective buffers or PBS at 4ºC. The refolded proteins were concentrated using 
Amicon® Stir Cell (Millipore; USA) using membranes (Millipore; USA) with 
suitable molecular weight cut-off pores. Purified recombinant proteins were stored 
at 4 ºC for immediate use and at -80 ˚C for long term storage. Protein 
concentration was measured using the Bradford assay, with BSA as the standard.  
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2.1.2 Generation of allergen- specific rabbit polyclonal antibodies 
 
New Zealand White Rabbits (2.5 to 3 kg) were purchased from the Centre for 
Animal Resources, Singapore and housed in the university Animal Holding Unit. 
Food and water were provided ad libitum. Animals were sacrificed by chemical 
euthanasia after the final harvest and disposed off as biohazard waste according to 
biosafety guidelines. Immunization was administered to the animals 
subcutaneously using 300 μg of recombinant protein diluted in a mixture of 500 μl 
of PBS and equal volume of Freund’s complete adjuvant (Sigma-Aldrich; 
Germany). Booster shots were repeated every 3 weeks with the same amount of 
recombinant protein, but using incomplete Freund’s adjuvant (Sigma-Aldrich; 
Germany) instead. All animals were housed at the Animal Holding Unit in the 
National University of Singapore throughout the duration of the antibody 
production work. After each booster shot, blood samples were obtained and 
animal antibody levels are titered using ELISA. A final harvest of blood was 
collected once the antibody titer was sufficiently maintained and the animals were 
finally sacrificed. The harvested blood was allowed to clot overnight at 4oC. 
Subsequently it is centrifuged at 3000 x g for 20 mins to obtain the sera, which 
were then stored in at -20oC.  
 
2.1.3 Generation of allergen- specific mouse monoclonal antibodies 
 
8 weeks-old female SPF BALB/c mice were purchased from the Centre for 
Animal Resources, Singapore and housed in the university Satellite Animal 
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Holding Unit. Food and water were provided ad libitum. Animals were sacrificed 
by carbon dioxide overdose after the final harvest and disposed off as biohazard 
waste according to biosafety guidelines. Mice were immunized intraperitoneally 
with 25 µg of each allergen (as described in 2.1.1) in Immuneasy Mouse Adjuvant 
(Qiagen; Germany) and boosted every three weeks until high titers of allergen-
specific antibodies were obtained. The hybridomas were produced by 
polyethelene glycol (PEG) fusion of myeloma cells and splenocytes from 
immunized mice in a ratio of 3:1. Hybridoma clones were screened through HAT 
(hypoxanthine, aminopterin and thymidine) (Sigma; Germany) selection followed 
by HT (hypoxanthine and thymidine) (Sigma; Germany) medium. The hybridoma 
clones were then screened with both whole mite extract and the specific allergens 
using enzymatic immuno assays. Producers were cloned twice by limiting dilution 
and the selected clones were further expanded in vitro. 
 
2.2 Determining sera IgE reactivity of Singaporean atopic population 
 
2.2.1 Human sera samples 
 
In this study, a collection of consecutive serum samples over a one year period 
from Singaporean patients with atopic clinical profiles were used for IgE 
reactivity screening. The sera were also screened for dust mite allergen reactivity 
by assaying with crude protein extracts of D. pteronyssinus, D. farinae and B. 
tropicalis.   
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2.2.2 Immuno dot blot  
 
For each serum sample, 1 μg of each recombinant protein to be assayed were 
dotted on a nitrocellulose membrane (BIO-RAD Laboratories; USA).  The 
membrane was allowed to dry at RT before being blocked with PBS-0.1% Tween-
20 for an hr. Following this, the membranes were incubated in dust mite reactive 
atopic patients’ sera overnight at 4ºC, followed by goat anti-human IgE 
conjugated with alkaline phosphatase (Sigma-Aldrich; Germany) diluted 1:1000 
for 2 hrs. Colorimetric reactions on the membranes were then detected by 
incubating with NBT/BCIP (nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl-
phosphate) (Promega; Madison, CA, USA). The Olympus MicromageTM for 
Windows version 3.01 (Olympus Optical; Germany) image analysis software was 
used to quantify the dot intensities. All membranes were washed three times with 
wash buffer (PBS-0.05 % Tween-20) in between every step of this assay before 
colour change detection. IgE-binding reactivity was categorized based on optical 
density (OD) of the immuno dot blot reactions: high (OD > 100), medium (50 > 









2.3 Quantification of dust mite allergens in Singaporean homes 
 
2.3.1 Dust samples 
 
Dust samples were collected from mattress, kitchen, sofa, carpet and bedroom 
floor areas of volunteer homes in Singapore. This collection was a separate 
exercise and did not correlate with the homes of atopic patients studied (refer to 
section 2.2.1.). Volunteer homes were randomly selected from around Singapore. 
An area of 1m2 for each area sampled was vacuumed for 2 mins using a modified 
Kirby Classic III vacuum cleaner (Kirby Co.; USA). 
 
2.3.2 Sample processing and allergen level quantification 
 
Dust samples collected were firstly sieved using a 500 μm pore-sized sieve. For 
every 50 mg of dust sample, 1 ml of PBS was added and then the solution was 
incubated overnight at 4ºC with shaking. The samples were then centrifuged at 
2500 rpm for 20 mins at 4ºC, and the supernatant collected was stored at -20 ºC. 
The supernatant (100 μl )of each individual dust samples was coated overnight at 
4°C onto monoclonal antibody-coated (as described in 2.1.3) wells in a microtiter 
plate (NUNC; Denmark) after the plate had been blocked with 1 % BSA in PBS 
for 30 mins at RT. Throughout the assay, wells were washed thrice with PBS-T 
(0.05 %) in between steps. Subsequently the wells were incubated overnight at 
4°C with 100 µl of anti-allergen rabbit IgG antibodies (as described in 2.1.2) at 
1:5000 dilutions in PBS. Wells were then washed and incubated with 1:1000 
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dilution of anti-rabbit IgG-conjugated horseradish peroxidase (BD Pharmingen; 
USA) in PBS for 3 hrs at RT. Wells were rinsed completely before addition of 
TMB (Sigma; USA). Finally, reactions were stopped using 20 μl of 1 M HCl and 
plates were read at 450 nm. 
 




7 week-old female SPF BALB/c mice were purchased from the Centre for Animal 
Resources, Singapore and housed in the university Satellite Animal Holding Unit. 
Mice were housed in separate cages according to treatment. Food and water were 
provided ad libitum. Animals were sacrificed by cervical dislocation under 
anesthesia at the completion of the study and disposed off as biohazard waste 
according to biosafety guidelines. 
 
2.4.2 Allergen exposure program 
 
Mice were held for a week before the commencement of the allergen exposure 
program. At the end of the holding period on day 0, mice were bled via the retro 
orbital sinus to obtain pre-exposure sera and screened for airway 
hyperresponsiveness (as described in 2.4.3; native Der p 1 from Indoor 
Biotechnologies; UK). Mice were sensitized on days 1 and 15 with an 
intraperitoneal injection of 0.5, 1, 2 or 4 μg of recombinant allergen protein (as 
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described in 2.1.1) suspended in PBS to a total volume of 200 μl. Subsequently, 
mice were administered daily challenges from day 16 through to day 19 using 
intranasal application of 1 μg of the same recombinant allergen protein suspended 
in PBS to a total volume of 50 μl. Non-sensitized animals received only the PBS 
solution. A final bleed was performed on day 20 to obtain post-exposure sera. All 
bleeding and intranasal challenges were performed under anesthesia. Harvested 
whole blood was allowed to clot overnight at 4oC before being centrifuged at 
3000x g for 20 mins to obtain the sera. 
 
2.4.3 Measurement of airway hyperresponsiveness 
 
Single-chamber whole body plethysmographs (Buxco Electronics, Inc.; 
Wilmington, NC, USA) were used to measure pulmonary function without the use 
of anesthesia or restraint on the animals. Airway resistance is expressed as Penh 
units using this non-invasive method. Mice were challenged on day 20, 24 hrs 
post-allergen challenge, with increasing doses of aerosolized methacholine (2.5, 5, 
10, and 20 mg/ml) and pulmonary functions were recorded. The initial Penh 
reading when animals were exposed to only 400 μl of aerosolized PBS solution 
for 2 mins was recorded as baseline Penh. An aerosol challenge in increasing 
methacholine dose (400 μl for each concentration) was administered via the 
Buxco Aerosol Delivery Unit (Buxco Electronics, Inc.; Wilmington, NC, USA) 
with duty cycle of 33 % for exactly 2.5 mins followed by a 0.6 min drying period 
for each dose. Animal pulmonary response data were then recorded for 5 mins and 
a mean of this period in terms of Penh was obtained. All Penh values for each 
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mouse were allowed to return to baseline before the next higher dose of 
methacholine was administered. The results of methacholine challenges were 
expressed as the percentage above baseline Penh index.  
 
2.4.4 Allergen-specific IgG1 and IgE quantification by ELISA  
 
For the quantification of allergen-specific IgG1, allergen proteins (as described in 
2.1.1) were coated overnight at 4˚C onto Maxisorp ELISA plate (NUNC; 
Denmark) at 0.5 μg per well (50 μl) in carbonate buffer. Plates were washed with 
PBS-T (PBS, 0.05 % Tween-20) and blocked with 100 μl of PBS-0.1 % Tween-
20-0.01 % BSA for 2 hrs at 37ºC. Murine sera samples were applied in dilutions 
of 1:100, 50 μl per well and in duplicates before being incubated at 4ºC overnight. 
HRP-conjugated anti-IgG1 (Zymed Laboratories Inc.; USA) were then applied, 50 
μl per well in 1:2000 dilution and incubated at RT for 2 hrs. Microtitre plates were 
thoroughly washed thrice with PBS-T between each step. Colorimetric reaction 
was developed for approximately 30 mins with the addition of 100 μl of TMB 
substrate (Sigma-Aldrich; Germany). Finally, the reaction was stopped by adding 
20 μl of 1 M HCl per well. Absorbance was measured at 450 nm using an ELISA 
plate reader. For the quantification of allergen-specific IgE, a 5-layer sandwich 
ELISA method was used due to the scarce IgE titers. Anti-mouse IgE monoclonal 
antibodies (BD Pharmingen; USA) were coated overnight at 4˚C onto Maxisorp 
ELISA plates (NUNC; Denmark) at 100 ng per well (50 μl) in carbonate buffer. 
Plates were washed with PBS-T (PBS, 0.05 % Tween-20) and blocked with 100 μl 
of PBS-0.1 % Tween-20-0.01 % BSA for 2 hrs at 37ºC. This is followed by 
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overnight incubation with mouse sera at ½ dilutions and a subsequent overnight 
incubation with specific allergens at 125 ng per well (2.5 μg/ml). The final 
overnight incubation with allergen-specific IgG (as described in 2.1.2) using either 
1:500 or 1:1000 dilutions was performed before addition of HRP-conjugated anti-
rabbit IgG (BD Pharmingen; USA) at 1:2000 dilutions and incubated at RT for 2 
hrs. Detection method was as described earlier for the quantification of IgG1 and 
plates were washed thrice with PBS-T between each step throughout the assay. 
 
2.4.5 Lung histology 
 
Upon completion of the methacholine challenges (as described in 2.4.3), mice 
were sacrificed by cervical dislocation under anesthesia. Mouse lungs were 
washed with 1 ml of PBS and distended with 10 % formalin solution. The 
collected tissues were then processed for microscopy. First, the lungs were 
dehydrated with a series of alcohol followed by clearing of dehydrant with 
histoclear. Then the tissues were infiltrated with paraffin wax as the embedding 
agent. Tissues embedded in wax were then sectioned using a microtome into 
samples of 5–7 microns thickness and mounted on microscopic slides. Dewaxing 
was then done to allow penetration of water-soluble dyes. The prepared murine 
lung sections were stained with hematoxylin and eosin dyes. Slides were analyzed 
under low power (X 10) for determination of lung tissue inflammation and for 






All protocols involving human sera were reviewed and approved by the 
Institutional Review Board of the Singapore General Hospital and the Hospital 
Ethics Committee of the KK Women's and Children's Hospital. Prior consent was 
obtained from owners of volunteer homes involved in the environmental dust 
sampling study. All animals used and animal research protocols were approved by 
the International Animal Care and Use Committee (IACUC) and the Animal 































Chapter 3: Results and Discussion 
 
3.1 IgE reactivity of Singapore atopic population 
 
 Sera from 162 atopic individuals in Singapore were assayed for IgE 
reactivity to the study panel of 7 allergen groups, comprising allergens: Der p 1, 
Der p 2, Blo t 3, Blo t 5, Der p 7, Blo t 12 and Der f 13. Specific serum IgE 
reactivity to each allergen was measured using colorimetric-based immuno dot 
blot assays. The sera reactions were quantified by unit optical density (OD), the 
unit of absorbance of which is directly proportional to the percentage of IgE 
binding. IgE-binding levels were then categorized as negative (OD < 20), low (20 
< OD < 50), moderate (50 < OD < 100), and high (OD > 100). 
114 (69.1%) out of the 162 atopic sera samples were determined as dust 
mite-sensitive sera by assaying with crude proteins of D. pteronyssinus, D. farinae 
and B. tropicalis. 50.9% of the dust mite-sensitive atopic individuals had positive 
reactions to Der p 2, followed by 39.5 % to Der p 1 and 35.1 % to Blo t 5. For the 
other allergens, reactions towards Blo t 3, Der f 13, Der p 7, and Blo t 12 were 
15.8 %, 19.3 %, 21.05 % and 26.3 % respectively (Figure 2).  
High positive reactions towards Der p 1 and Der p 2 were expected due to 
the known identification of group 1 and 2 allergens as major allergens with high 
IgE-binding frequencies (Chapman et al., 1980; Van der Zee et al., 1988; Lind  
et al., 1983). Serum IgE reactivity for Blo t 5 which is identified as a major 
allergen of B. tropicalis (Caraballo et al., 1996) ranked third highest among the 
allergens screened. These data correlated with those among the atopic population 
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of tropical Singapore, Dermatophagoides (Lee et al., 1994 & 1989) and Blomia 
(Lee et al., 1997 & 1996) allergens are co-sensitizers (Fernandez-Caldas et al., 
1998; Hage- Hamsten et al., 1995). 19.3% of the dust mite-sensitive atopic sera 
responded towards Der f 13, despite D. farinae representing only about 1 % of 
mite fauna found in Singapore (Chew et al., 1999). This is most probably due to 




























Figure 2 The number of dust mite-sensitive individuals showing IgE reactivity to 
each recombinant allergen group. Reactive sera were defined as sera with positive 
OD of > 20. The percentage of patients reacting to each allergen is calculated 
based on 114 dust mite-sensitive individuals from a total of 162 Singaporean 








 The bulk of the positive sera reactions for each allergen was of the low 
reactivity category (20 < OD < 50) (Figure 3). Der p 2 had the highest number of 
reactors for high, moderate and low categories. Among the panel of allergens 
investigated in this study, we can conclude that allergens with both high frequency 
and magnitude of IgE-binding are Der p 2, Der p 1 and Blo t 5. Among the 
allergens with low IgE-binding capacity were Der f 13 > Blo t 3 > Der p7 > Blo t 
12 (magnitude) and Blo t 12 > Der p 7 > Der f 13 > Blo t 3 (frequency). 
 
 
























Figure 3 IgE-binding of sera from Singaporean atopic individuals to 7 allergen 
groups. The percentage of IgE-binding is expressed as optical density (OD) and 
categorized by specific reaction levels: low (20 < OD < 50), moderate (50 < OD <  




 Atopic serum IgE reactivity profiles of dust mite-sensitive individuals tells 
us which dust mite allergens in our panel of study are Singaporeans reacting to 
and the amount of sensitization. Identifying specific dust mite allergens will aid in 
the study of the role of host response in disease pathogenesis. We then proceeded 
to investigate if the degree of dust mite sensitization is due to concentration levels 
in the local environmental dust, to the intrinsic allergenic property of the 
respective allergen proteins or a combination of both. 
 
3.2 Distribution of allergens in environmental dust samples 
 
In order to investigate if the degree of dust mite sensitization is due to 
exposure levels in the local environment, dust samples were collected from 
Singaporean homes and assayed with ELISA for concentrations of Der p 1, Der p 
2, Blo t 3, Blo t 5, Der p 7, Blo t 12 and Der f 13, representing the major dust mite 
allergen groups of 1, 2, 3, 5, 7, 12 and 13. In the serum IgE reactivity study, Der p 
2, Der p 1 and Blo t 5 had been identified as allergens with both high frequency 
and magnitude of IgE-binding whereas the other groups were categorized with 
low IgE-binding frequency and magnitude. Dust samples were obtained by 
vacuuming 5 areas within each home: bed, carpet, kitchen, sofa, and bedroom 
floor, using methods described.  
The range of mean concentration detected for each of the allergen groups 
(Figure 4) is as follows: Der p 1 (1.5–10.9 μg/g dust) Der p 2 (4.3–7.7 μg/g dust), 
Blo t 5 (2.5–6.3 μg/g dust), and Der f 13 (1.6–3.5 μg/g dust). Blo t 3 (< 0.2 μg/g 
dust) and Der p 7 (< 0.6 μg/g dust) concentrations were very low in all sampled 
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areas but still detectable compared to Blo t 12 levels which were below the assay 
detection limits. Der p 1 and Der p 2 were the dominant allergens found in bed 
samples. For carpet samples, Der p 1 concentrations were the highest as were Der 
p 2 in bedroom floor samples. In kitchen, sofa and bedroom floor dust, the 


































  Bed      Carpet           Kitchen     Sofa           Floor 
  
Dust sample source 
Figure 4 Distribution of dust mite allergens in Singaporean homes. Data 
presented as mean concentrations for each allergen (A-F) in each area sampled: 
beds (n = 51; 53; 26; 36; 26; 36), carpets (n=9; 9; 3; 6; 3; 6), kitchens (n = 7; 9; 5; 
15 ;5 ;15), sofas (n = 16; 14; 22; 36; 22; 36) and floors (n = 15; 12; 8; 23; 19; 24). 






For Der p 1, Der p 2, and Blo t 5 allergens, the highest mean 
concentrations detected ranged from 6.3–10.9 μg/g dust. These amounts of 
exposure already exceed the reported levels that can be considered as risk factors 
for sensitization to mites, asthma development and bronchial hyperreactivity in 
genetically predisposed individuals (Lau et al., 1989; Sporik et al., 1990; Arruda 
et al., 1991; Fernandez-Caldas et al., 1999). It is also known that the risk of 
sensitization increases with increasing doses. The mean for Der p 1 found in this 
study was also higher than previously reported (Zhang et al., 1997).  
Der p 1 was detected mostly in bed and carpet samples, Der p 2 in bed and 
bedroom floor samples, Blo t 3 and Der p 7 in sofa samples, Blo t 5 in kitchen and 
bedroom floor samples while Der f 13 concentrations were equally distributed 
over all the areas sampled except for sofa samples (Figure 5). The highest 
concentration recorded in a single sample was for 65 μg/g dust for Der p 1 and 22 
μg/g dust for Der p 2. Blo t 5 and Der f 13 both recorded the highest concentration 
in a single sample of 10 μg/g dust. The most Der p 7 detected in a single sample 
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Figure 5 Concentration of dust mite allergens in dust samples from Singaporean 
homes. Dust samples collected were assayed for concentrations of the allergens in 
beds (n=51; 53; 26; 36; 26; 36), carpets (n=9; 9; 3; 6; 3; 6), kitchens (n=7; 9; 5; 15; 
5 ;15), sofas (n=16; 14; 22; 36; 22; 36) and floors (n=15; 12; 8; 23; 19; 24). Mean 
concentration for each allergen is denoted by the horizontal bars in each scatter 




Therefore, Der p 1 and Der p 2 can be categorized as having high 
environmental distribution, Blo t 5 and Der f 13 as moderate and Der p 7, Blo t 3 
and Blo t 12 as poorly distributed. The dust data for Der p 1 and Der p 2 support 
the degree of sensitization shown for both allergen groups in the serum reactivity 
profile of the Singaporean atopic population. Subsequently, how these allergens 
interact in a host system was investigated using responder animals in the context 
of modeling atopic asthma. 
 
3.3 Murine model of dust mite allergen-induced atopic asthma 
 
Female 8-week old SPF BALB/c mice representing a responder population 
were exposed to native Der p 1 and recombinant Der p 2, Blo t 3, Blo t 5, Der p 7, 
Blo t 12 and Der f 13 allergen proteins according to the exposure protocol 
described. Native Der p 1 (INDOOR Biotechnologies; UK) was used as the 
recombinant allergen did not fold properly to preserve its proteolytic activity. For 
each allergen group studied, 4 immunization doses were tested: 0.5, 1, 2, and 4 μg 
(except for Blo t 5 where the doses were increased to 1, 5, 10, and 20 μg 
respectively; refer to explanation is given in section 3.3.1). For every dose, a total 







3.3.1 Airway hyperresponsiveness (AHR) 
  
Specific response such as airway narrowing to exposure of substances with 
allergenic properties (e.g. allergens) constitue one of the hallmarks of atopic 
asthma. Airway hyperresponsiveness is a parameter indicative of the allergen’s 
capacity to induce lung bronchoconstriction. Assessment of the airway response 
was performed by challenging the lungs with methacholine, a non-specific agonist. 
Both asthmatic and non-asthmatic subjects can respond to a non-specific stimulus 
such as methacholine, but differ in magnitude depending on dose concentrations 
and airway sensitivity. The animals’ mechanical parameter of airway resistance to 
methacholine is measured as Enhanced Pause (Penh), a dimensionless unit. In this 
report, absolute Penh values were converted into “percentage above baseline 
Penh” indices. The percentage increase above baseline Penh index charts the 
host’s response towards inhaled methacholine along a dose-response curve 
calculated based upon the baseline Penh value (whereby baseline Penh is the 
measurement of pulmonary response to administration of aerosolized PBS 








Mice exposed to native Der p 1 protein did not exhibit any specific 
trending of AHR with increasing methacholine concentrations (Figure 6). At the 
highest methacholine concentration of 0.1 M, all immunization doses recorded 
200–370% increase above baseline Penh except for mice given immunization dose 
of 2 μg which dipped instead of increasing. Resulting Penh variance between the 
animals increased with increasing methacholine concentrations. The greatest 
reactivity was shown for mice given the immunization doses of 1 μg (R2 = 0.9961). 
Animals given different immunization doses did not display differential AHR 
towards native Der p 1. This suggests that perhaps a lower immunization dose of 
native Der p 1 (lower than 1 μg) along with booster immunizations/challenges 
over a longer period of exposure might elicit a more significant magnitude of 
response. This would be consistent with published results that only 1 μg of Der p 































Figure 6 Der p 1-induced murine AHR. Each dose response curve is plotted with 
mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 
trendlines not shown. 
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Mice exposed to recombinant Der p 2 protein exhibited dose-dependent 
increased airway hyperresponsiveness with increasing methacholine 
concentrations (Figure 7). At the highest methacholine concentration of 0.1 M, 
mice given immunization dose of 4 μg recorded almost 500 % increase above 
baseline Penh compared to those given the lowest immunization dose of 0.5 μg 
(almost 300 % increase above baseline Penh). Resulting Penh variance between 
the animals given the highest immunization dose was also the greatest in 
comparison to the animals given lower doses. The greatest reactivity were shown 
for mice given the immunization doses of 2 μg (R2 = 0.9776) and 4 μg  

































Figure 7 Der p 2-induced murine AHR. Each dose response curve is plotted with 
mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 




Mice exposed to recombinant Blo t 3 protein exhibited increased airway 
hyperresponsiveness with increasing concentrations of methacholine (Figure 8). 
At the highest methacholine concentration of 0.1 M, mice given immunization 
dose of 4 μg recorded 250% increase above baseline Penh compared to those 
given the lowest immunization dose of 0.5 μg (almost 75% increase above 
baseline Penh). Resulting Penh variance between the animals given the highest 
immunization dose was also the greatest in comparison to the animals given lower 
doses. The greatest reactivity was shown for mice given the immunization dose of 































Figure 8 Blo t 3-induced murine AHR. Each dose response curve is plotted with 
mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 





The initial experiments with Blo t 5 used immunization doses of 0.5, 1, 2, 
and 4 μg, which failed to produce any clear AHR trending as well as differential 
response between the doses (data not shown). The immunization doses were thus 
increased 5-fold to 1, 5, 10, and 20 μg, resulting in increased airway 
hyperresponsiveness with increasing methacholine concentrations (Figure 9). At 
the highest methacholine concentration of 0.1 M, mice immunized with doses of 
10 and 20 μg recorded almost 325 % increase above baseline Penh compared to 
those given the lowest immunization dose of 1 μg (almost 30 % increase above 
baseline Penh). Resulting Penh variance between the animals given the highest 
immunization dose was also the greatest compared to animals given lower doses. 
The greatest reactivity was shown for mice given the immunization dose of 20 μg 































Figure 9 Blo t 5-induced murine AHR. Each dose response curve is plotted with 
mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 
trendlines not shown. 
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Mice exposed to recombinant Der p 7 protein exhibited increased airway 
hyperresponsiveness with increasing methacholine concentrations (Figure 10) but 
with no dose-dependency. At the highest methacholine concentration of 0.1 M, 
mice given immunization doses of 2 and 4 μg recorded almost 250 % increases 
above baseline Penh compared to those given the lowest immunization dose of 0.5 
μg (almost 50 % increase above baseline Penh). Resulting Penh variance between 
the animals given the highest immunization dose was also the greatest in 
comparison to the animals given lower doses. The greatest reactivity was shown 
for mice given the immunization dose of 4 μg (R2 = 0.9328) while the reactivity 
graphs of mice administered lower doses appeared to plateau instead or increasing 



































Figure 10 Der p 7-induced murine AHR. Each dose response curve is plotted with 
mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 




Mice exposed to recombinant Blo t 12 protein exhibited increased 
hyperresponsiveness with increasing concentrations of methacholine (Figure 11), 
but with higher immunization doses resulting in airway suppression compared to 
lower immunization doses. At the highest methacholine concentration of 0.1 M, 
all immunization doses recorded percentage increases above baseline Penh of 
300–325%. Resulting Penh variance between the animals given the lowest 
immunization dose was also the greatest in comparison to the animals given 
higher doses. The greatest reactivity was shown for mice given the immunization 

































Figure 11 Blo t 12-induced murine AHR. Each dose response curve is plotted 
with mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 
trendlines not shown. 
 
This suppression of AHR with higher immunization dose could be 
attributed to high-dose tolerance, suggesting that reactivity can be measured with 
a lower dose range. However, compared to the other allergen groups studied, the 
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Blo t 12 allergen group is not known to be a potent allergen. Thus, it is possible 
that the intrinsic properties of Blo t 12 allergen work differently in eliciting an 
immunological response when compared to other allergens studied thus far.  
 
Mice exposed to recombinant Der f 13 protein exhibited increased 
hyperresponsiveness with increasing concentrations of methacholine (Figure 12) 
but with higher immunization dose resulting in AHR suppression compared to 
lower immunization doses, similar to the AHR profile of Blo t 12. At the highest 
methacholine concentration of 0.1 M, mice given immunization dose of 0.5 μg 
recorded almost 400% increase above baseline Penh. Resulting Penh variance 
between the animals given the lowest immunization dose was also the greatest in 
comparison to the animals given higher doses. The greatest reactivity was shown 































Figure 12 Der f 13-induced murine AHR. Each dose response curve is plotted 
with mean data of 4 animals and variance between the 4 animals for each dose is 
shown as SD error bars on each respective dose response curve. Logarithmic 
trendlines not shown. 
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When compared with Blo t 12, Der f 13 also appeared to induce AHR 
suppression at higher immunization doses but with more allergenic strength. 
Similarly, this suppression of AHR with higher immunization dose could be 
attributed to the intrinsic properties of the Der f 13 allergen in inducing a different 
immunological response from the murine host. The Der f 13 allergen is not known 
to be a potent allergen compared to Der p 1, Der  p 2 or Blo t 5. 
 
 
3.3.2 Sera antibody profile response 
Besides studying the murine AHR profiles induced by the allergens, serum 
antibody profiles were investigated to shed light on the allergenicity of the 
recombinant allergen proteins in inducing a systemic response. Elevated antigen-
specific serum IgG1 and IgE titers are hallmark parameters in murine models of 
atopic asthma (Jungsuwadee et al., 2002; Holt et al., 1991). Mast cells are 
activated by the cross-linking of allergen-specific IgE on its surface which causes 
release of inflammatory mediator that contribute towards AHR (Djukanovic et al., 
1990) in asthma pathogenesis. IgG1 has also been increasingly implicated in 
mediating AHR by its capacity to sensitize murine mast cells independent of IgE 
(Macedo-Soares et al., 2004; Mehlhop et al., 1997; Oshiba et al., 1996), in 
addition to being the only immunoglobulin class other than IgE in mice that are 
able to cross-link mast cell FcεRI receptors. 
Blood samples were collected from each animal before and after the 
allergen exposure period to obtain pre- and post-exposure sera antibody profiles 
which were assayed by ELISA using laboratory-raised rabbit antibodies specific 
against the allergens and commercially available anti-IgG1 and anti-IgE 
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antibodies. Direct ELISA was used to assay for allergen-specific IgG1 antibodies 
whereas sandwich ELISA was used to detect the scarcer amounts of allergen-
specific IgE antibodies. Due to the low levels of OD readings obtained, results in 
this report were expressed as the difference between OD readings of pre- and 
post-exposure sera to reflect the change in antibody response. Pre-exposure sera 
for animals of each allergen exposure were taken as controls against the post-
exposure sera. 
 For murine IgG1 antibody response (Figure 13), Blo t 3 induced the 
highest amount of antibodies produced for all immunization doses whereas Blo t 5 
induced the lowest amount despite immunization doses being 5 times higher than 
for all other allergens. Almost all allergens induced production of allergen-
specific antibodies in an immunization dose-dependent manner except for Der p 7, 
which exhibited suppression of IgG1 levels produced at higher immunization 
doses. For murine IgE antibody response (Figure 14), Der p 2 induced the highest 
amount of antibodies produced for all immunization doses whereas Der f 13 
induced the lowest amount. All the allergens induced production of allergen-

























Figure 13 Allergen-induced murine sera IgG1 profile. Bar graph values plotted as 
difference between pre- and post-exposure sera OD readings. Sera samples were 
pooled from 4 animals within each allergen group and dose. For Blo t 5, 
































Figure 14 Allergen-induced murine sera IgE profile response. Bar graph values 
plotted as difference between pre- and post-exposure sera OD readings. Sera 
samples were pooled from 4 animals within each allergen group and dose. For Blo 




Native Der p 1, and Der p 2 induced about twice as much IgG1 compared 
to IgE in allergen-exposed mice. Blo t 3 induced 5 times more IgG1 than allergen-
specific IgE. Blo t 5 on the other hand produced approximately the same amount 
of both allergen-specific antibodies even with immunization doses 5 times more 
than the other mice exposed to the rest of the allergens. Der p 7 produced about 6 
to10 times more IgG1 than IgE at lower doses but approximately the same amount 
of both antibodies at higher doses.  
In Blo t 12- and Der f 13-exposed mice, production of IgG1 was about 10 
times more than IgE levels. Consequently, the predominant production of IgG1 
rather than IgE with these two groups may characterize the AHR response seen 
with the two allergen groups. Despite having lower allergenic potency, Blo t 12 
and Der f 13 allergens are able to induce AHR at lower doses via IgG1 rather than 
IgE. However, further characterization is needed to provide more conclusive 
explanation regarding the suppression of airway responses with higher doses of 
Blo t 12 and Der f 13.  
 
3.3.3 Lung histology studies 
  
 Distended murine lungs kept in 10% formalin solution were processed and 
tissues embedded in paraffin wax. Sections were cut with a microtome to about 5 -
7 microns thick, dewaxed and mounted on microscopic slides before being stained 
with hematoxylin and eosin dyes. Hematoxylin visualizes the nucleic acids of cell 
nuclei and eosin stains the cell cytoplasmic components. Slides were observed 
under the microscope for changes indicative of allergen-induced inflammation in 
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the lungs: cellular infiltration such as macrophages and eosinophils, mucus 
hypersecretion or smooth muscle hypertrophy.  
 However, microscopic slides of lung sections of all allergen-exposed mice 
studied did not reveal any significant inflammation observations when compared 
to lung sections from control mice exposed to phosphate buffered saline (PBS). 
Mice are known to develop AHR without histologic airway inflammation when 
the allergen is administered only through the respiratory route (Hessel et al., 1995; 
Renz et al., 1992). In this study, animals were first immunized via an 
intraperitoneal injection of allergen solutions without adjuvant, followed by a 
booster intraperitoneal injection and subsequent 4 daily intranasal challenges. 
Thus the lack of lung inflammation observed may be attributed to the route of 
allergen administration employed as well as the low dosage of allergen given in 
the absence of adjuvants. The short exposure duration and subsequent low levels 












Chapter 4: Conclusion 
 
 In this study, it was initially observed that different dust mite-sensitive 
individuals in an atopic population reacted to different groups of dust mite 
allergens with varying degrees of magnitude and frequency of IgE-binding. A 
panel was created with selected allergens of different species representing the 
major dust mite allergen groups: Der p 1, Der p 2, Blo t 3, Blo t 5, Der p 7, Blo t 
12, and Der f 13. Selection criteria were based on the known IgE reactivity profile 
of the allergens and characterization information already published or available in 
the laboratory. The studies of the serum allergen-specific IgE reactivity in the 
local atopic population and the environmental distribution of dust mite allergens 
showed interesting patterns for the different allergen groups inducing differential 
host immunological responses. The specific dust mite allergen-induced responses 
for each of the allergen groups studied are summarized in the following 
paragraphs:  
Major allergens such as groups 1 and 2 had specific environmental niche 
concentrations with high exposure (distribution concentrated in bed and bedroom 
floor samples) that directly corresponded to the magnitude and frequency of IgE-
binding. Thus, the capacity of major allergen groups 1 and 2 in invoking an 
immune response are expected to be high. Futhermore, there are studies that 
suggested that the proteolytic activity of the group 1 allergens may provide an 
adjuvant effect such as the cleavage of CD23 (Schulz et al., 1997; Hewitt et al., 
1995) which is important in the regulation of IgE responses. However, native  
Der p 1 did not induce a clear AHR in Der p 1-exposed mice. Immunization with 
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Der p 1 produced twice as much IgG1 than IgE. The lack of significant AHR may 
be attributed to the fact that atopic mice produce different immune responses 
towards allergenic fractions of a mite extract. High molecular weight-allergenic 
fraction (HM1) abundant in D. farinae extracts aggravated AHR in mice rather 
than the HM1-depleted fecal extract (Tategaki et al., 2002). Der p 1 is known to 
be about 25kDa in size, which is excluded from the range of the high-molecular-
weight allergenic fraction. Sera IgE reactivity and house dust data corroborated 
the role of group 2 as a major dust mite allergen group.  Der p 2 also induced 
dose-dependent increased AHR in immunized mice with production of IgG1 twice 
the amount IgE. These data suggest that high amounts of group 2 allergens in 
concentrated exposure areas such as beds, and the intrinsic allergenicity of the 
protein elicit more significant atopic presentations compared to major allergen 
group 1. 
Group 13 allergens are most similar in size and function compared to 
group 2 allergens. Der f 13 is known to be a fatty acid binding protein (FABP) of 
about 14 kDa in size. High concentrations of group 13 allergens in the 
environment do not increase its sensitization capacity or its ability to elevate AHR. 
While group 2 exhibited immunization dose-dependent increase of AHR response 
to methacholine, group 13 suppressed AHR with increasing immunization doses 
at comparable reactivity levels. Similar to group 7, group 13 also produced ten 
times more IgG1 compared to IgE titers in immunized mice. This suggests a role 
for the immunoglobulin in mediating inflammatory responses. A possible 
explanation for this suppression observation may attributed to the function and 
structure similarity of  group 13 to the family of lipocalin proteins. Its effective 
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dispersion in environmental dust, low stimulation capacity for T-cell proliferation 
(unpublished data), endogenous FABPs capacity to bind IgE  and positive skin 
prick test results (Chan et al, 2006) support a possible role as an allergen with 
immunomodulatory properties.  
Group 12 allergen also suppressed AHR at higher immunization doses but 
with less airway reactivity magnitude than group 13 allergens. Group 12 also 
share size similarity with group 2 and 3 allergens. Among the low IgE-binding 
capacity dust mite allergens, group 12 showed the highest frequency but the 
lowest magnitude. The IgG1 levels induced in Blo t 12-exposed mice were 10 
times greater than the titers of IgE produced.  With its scarce distribution in house 
dust compared to major groups such as 1 or 2, it can only be inferred that although 
not very allergenic, high immunization doses of group 12 produces high IgG1 
levels that may possibly modulate AHR response in mice. The lack of published 
work on group 12 allergens thus far and its unknown function do not allow more 
complete information on its allergenicity. 
Group 7 allergen demonstrated the ability to induce AHR response with 
increasing methacholine concentrations and to sensitize an atopic population. It is 
the only allergen group to demonstrate a reversal in allergen dose-dependent 
production of IgE and IgG1, with titers of IgG1 being 6–10 times more than IgE 
titers at lower doses, which warrants further investigation. It can only be inferred 
that group 7 allergens are immunogenic and can elicit immune responses different 
from the major allergen groups such as 1 and 2. It is also possible that group 7 
induces immunologic tolerance (Platts-Mills et al., 2000) at low sensitization 
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doses. However, the IgE-binding capacity of Group 12 was not significant enough 
to describe its allergenicity. 
Group 5 allergens have both high IgE-binding frequency and magnitude 
but are not as well represented in the environment as well as the group 1 and 2 
allergens. However, compared with the relatively low reactivity and distribution 
of Group 3 and 12 allergens, it certainly has a higher sensitization risk. 
Nonetheless, substantial environmental concentrations and IgE-binding capacity 
do not correlate with its ability to invoke a systemic immune response. It required 
5 times more allergen than group 3 in order to induce a clear AHR response. At 
the immunization dose of 10 μg, group 5 induced only slightly more airway 
reactivity than the magnitude induced by group 3 at the immunization dose of 1 
μg. It can be concluded that Group 5 allergens depend on high exposure levels in 
order to invoke a stronger immune response. Group 3 allergen’s low allergenicity 
may be attributed to it being highly susceptible to degradation in the environment 
(Stewart et al., 1989). Size of the allergen may also play a role as group 3 
allergens are almost twice as large as Group 5 ones. 
What we may conclude at this stage is that clearly, the different groups of 
allergens interact specifically and differently with the host to induce 
immunological responses. Combined observations from the local population sera 
IgE reactivity screen, the environmental dust screens and the immunological 
responses of the murine model of atopic asthma pointed towards the inherent 
properties of the dust mite allergen groups as the source of these different 
responses. It is of great interest to study how well-dispersed allergens with low 
concentrations such as group 5 and 13 (both with opposite sensitization profiles) 
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affect the pathogenesis of atopic diseases. These groups which are less well-
characterized compared to Groups 1 and 2 may yield insights into the dust mite 
allergens which are clinically important triggers for bronchial asthma in the 
context of the typical Singapore household and sensitization patterns. Comparison 
studies can also be drawn between group 2 and 13 allergens with their structure 
and function similarity but opposite sensitization and AHR profiles.  
More characterization work needs to be done to elucidate the functions of 
these allergens which would help to determine why some people are not allergic 
and how the allergen-host interaction plays out in the pathogenesis of atopic 
diseases such as asthma. Future directions for this study would include 
investigating the allergen-induced proteomic and genomic responses in a murine 
host to better characterize the allergen groups besides yielding putative molecular 
markers to target in delineating the pathogenesis of asthma. Further work utilizing 
immunological assays such as BAL fluid profiling for lung cytokines and other 
mediators can also be carried out to characterize the animal host immunological 
response. Refinements could also be done on the existing murine model such as 
the duration of the allergen exposure protocol and dosage of immunizations. 
These invaluable murine set of data can then be combined with genetic data from 
genomic screens of human atopic/asthmatic subjects to allow for possible 
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